Key Indicators

NACTRC aims to provide the research community with the highest level of support. As part of this commitment, we’ll be publishing key indicators here on our website.

Type of Agreement	Agreement & Activity Types	Current service times for 2025 (business days)
1 – High complexity	Clinical trial agreements involving a CRO High risk matters: Foreign legal jurisdiction, biosafety considerations, etc. requiring additional approval. US Federal studies: FDA/IRS considerations Multi-party/project agreements: Collaboration, Master, Subsite, etc.	Varies significantly, but typically 90-120 business days
2 – Intermediate complexity	Routine clinical trial agreements directly with Pharma Subsite agreements with other Universities/Colleges (Canada)	45–80 days 50–90 days
3 – Routine	Compassionate use agreements Confidential disclosure agreements Amendments Work orders to master agreements	1 day 8–10 days 6–8 days 3–6 days